Awareness and Knowledge of Pharmacists toward Biosimilar Medicines: A Survey in Jordan

Table 3

Univariate and multivariate analysis of factors affecting the pharmacists’ knowledge.

All participants	Univariate analysis		Multivariate analysis
	Not knowledgeable	Knowledgeable	value	Or (95%CI)	value
Gender
Female	186 (78.2)	193 (73.1)	0.189	Ref 1.202 (0.778–1.859)	0.407
Male	52 (21.8), 186 (78.2)	71 (26.9)
Age
21–30	183 (76.9)	208 (78.8)	0.697
31–40	36 (15.1)	40 (15.2)
Above 40	19 (8.0)	16 (6.1)
Area of residence
Amman	125 (52.5)	140 (53.0)	0.909
Other than Amman	113 (47.5)	124 (47.0)
BSc degree type
Pharmacy	219 (92)	237 (89.8)	0.384
Pharm D	19 (8)	27 (10.2)
Professional specialty
Community	104 (43.7)	128 (48.5)	0.283
Pharmacist others	134 (56.3)	136 (51.5)
Length of service as in professional specialty
>10 years	26 (10.9)	32 (12.1)	0.135	Ref 0.945 (0.510–1.750); 0.64 (0.338–1.213); 1.196 (0.617–2.317)	0.708
<1 year	90 (37.8)	110 (41.7)
1–3 years	77 (32.4)	61 (23.1)
4–10 years	45 (18.9)	61 (23.1)
Type of graduate university
Public	168 (70.6)	190 (72.0)	0.733
Private	70 (29.4)	74 (28.0)
Hearing about biosimilars
No	65 (27.3)	40 (15.2)	0.001	Ref 1.942 (1.231–3.063)	0.004
Yes	173 (72.7)	224 (84.8)
Biosimilars course or post-graduating training course
Yes	46 (19.3)	85 (32.2)	0.001	Ref 0.548 (0.357–0.839)	0.006
No	192 (80.7)	179 (67.8)